2015
DOI: 10.1002/mnfr.201400164
|View full text |Cite
|
Sign up to set email alerts
|

Rosmarinic acid exerts an antiosteoporotic effect in the RANKL-induced mouse model of bone loss by promotion of osteoblastic differentiation and inhibition of osteoclastic differentiation

Abstract: Rosmarinic acid has dual regulatory effects on bone metabolism and may control the bone functions by controlling osteoblastic and osteoclastic differentiation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
12
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(16 citation statements)
references
References 64 publications
(76 reference statements)
1
12
0
Order By: Relevance
“…As a result, eleven bioactive compounds (rosmarinic acid, citrusin C, nepetoidin B, tilianin, isoagastachoside, apigetrin, phlorizin, luteolin, diosmetin, apigenin, and acacetin-7- O -(3”- O -acetyl)-β- d -glucopyranoside) inhibited RANKL-induced osteoclast differentiation ( Figure 5 ). Similar to our results, previous studies have shown that rosmarinic acid inhibits RANKL-induced bone loss via suppression of p38-mediated osteoclast differentiation [ 44 ], and diosmetin decreases LPS-induced osteolysis via inhibition of ERK, JNK, and reactive oxygen species-mediated osteoclast formation and differentiation [ 45 ]. In addition, phlorizin, luteolin, and apigenin prevent OVX-induced postmenopausal bone loss [ 46 , 47 , 48 ].…”
Section: Resultssupporting
confidence: 92%
“…As a result, eleven bioactive compounds (rosmarinic acid, citrusin C, nepetoidin B, tilianin, isoagastachoside, apigetrin, phlorizin, luteolin, diosmetin, apigenin, and acacetin-7- O -(3”- O -acetyl)-β- d -glucopyranoside) inhibited RANKL-induced osteoclast differentiation ( Figure 5 ). Similar to our results, previous studies have shown that rosmarinic acid inhibits RANKL-induced bone loss via suppression of p38-mediated osteoclast differentiation [ 44 ], and diosmetin decreases LPS-induced osteolysis via inhibition of ERK, JNK, and reactive oxygen species-mediated osteoclast formation and differentiation [ 45 ]. In addition, phlorizin, luteolin, and apigenin prevent OVX-induced postmenopausal bone loss [ 46 , 47 , 48 ].…”
Section: Resultssupporting
confidence: 92%
“…This finding is consistent with the fact that SM extract is used to mitigate renal oxidative, inflammatory, and glycative stresses, as well as to reduce cytokine productions. In addition, ellagic acid (Papoutsi and others ), which has potent antiinflammatory activity, ferulic acid, which possesses strong anti‐oxidative activity (Itagaki and others ), and Rosmarinic acid, which is thought to have anti‐osteoporotic effect (Lee and others ), are all enriched in SM extracts. Considering that oxidative stress and inflammation are 2 major factors involved in the pathogenesis of osteoporosis, the rich content of antioxidants and anti‐inflammatory compounds in SM extracts should contribute to its use as an anti‐osteoporotic agent.…”
Section: Resultsmentioning
confidence: 99%
“…Overall, several bioactive compounds can potentially inhibit bone resorption by acting on osteoclasts which are the only cells capable of this role (25,29,30,(44)(45)(46). It is plausible that such mechanism plays an important role in managing feline idiopathic hypercalcemia.…”
Section: Discussionmentioning
confidence: 99%
“…Several nutrients present in chia seeds, such as omega-3 fatty acids, soluble and insoluble fibers, polyphenols, and flavonoids, can affect calcium metabolism (25,29,30,(44)(45)(46). It is reasonable to say that normalization of ionized calcium concentrations in feline idiopathic hypercalcemia is ascribable not to one single nutrient, but more seemingly to the combined effects of all these bioactive compounds.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation